SCHEMBL26206356

SCHEMBL26206356

C[C@@H](CCC(N)=O)COCCCCCCCCC(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.44
▸ PLA2G2C Q5R387 1/20 0.43
▸ TSHR P16473 5/20 0.38
▸ LMNA P02545 2/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ PMP22 Q01453 1/20 0.38
▸ EPHX2 P34913 1/20 0.38
▸ KMT2A Q03164 3/20 0.37
▸ MAPT P10636 1/20 0.37
▸ FFAR4 Q5NUL3 2/20 0.37
▸ FFAR1 O14842 2/20 0.37
▸ PPARG P37231 6/20 0.36
▸ PPARD Q03181 6/20 0.36
▸ PPARA Q07869 6/20 0.36
▸ HDAC11 Q96DB2 5/20 0.36
▸ GPR84 Q9NQS5 4/20 0.36
▸ TLR2 O60603 2/20 0.36
▸ TDP1 Q9NUW8 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ FABP4 P15090 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26206360 1.00 ALDH1A1 (0.44) ALDH1A1PLA2G2CTSHRLMNANFKB1
SCHEMBL26206355 1.00 ALDH1A1 (0.44) ALDH1A1PLA2G2CTSHRLMNANFKB1
SCHEMBL26205615 0.88 PAOX (0.39) PLA2G2CPMP22EPHX2KMT2ATLR2
SCHEMBL26205613 0.82 CYP1A2 (0.42) ALDH1A1TSHRLMNAEPHX2KMT2A
SCHEMBL26205612 0.82 CYP1A2 (0.42) ALDH1A1TSHRLMNAEPHX2KMT2A
SCHEMBL26206496 0.80 PTPN7 (0.45) ALDH1A1EPHX2KMT2AMAPTTDP1
SCHEMBL12355357 0.80 ALDH1A1 (0.50) ALDH1A1PLA2G2CTSHRLMNANFKB1
SCHEMBL26206347 0.79 FFAR1 (0.47) ALDH1A1LMNAFFAR1HSD17B10
SCHEMBL10596601 0.78 ALDH1A1 (0.55) ALDH1A1PLA2G2CTSHRLMNANFKB1
SCHEMBL2090432 0.78 SPHK1 (0.42) ALDH1A1PLA2G2CKMT2AMAPTTLR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11746120-B2 Stat degraders and uses thereof KYMERA THERAPEUTICS, INC. (US) 2023-09-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11746120-B2 Stat degraders and uses thereof STAT4, STAT1, STAT3 ALDH1A1 2465/4885PLA2G2C 1935/4885TSHR 1768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback